![]() | Only 14 pages are availabe for public view |
Abstract RF ablation is a local percutaneous tumor treatment that has many potential applications in the thorax. A number of studies are under way to quantify its efficacy in both primary and metastatic neoplasms of the thorax. The goal of such a minimally invasive local therapy is to provide a consistent zone of tumor necrosis without the additional complications that are inherent with a surgical procedure that requires general anesthesia, chest tube drainage, and hospitalization. It is a safe and relatively straightforward minimally invasive procedure for the treatment of lung cancers. RF therapy can potentially be used as an adjuvant therapy to systemic anticancer treatment, including chemotherapy or chemotherapy and radiation therapy, to decrease the tumor cell volume with reasonably low morbidity and mortality. |